Stepan

US · SCL #3013 by market cap Listed 1970

61.32 -1.07 -1.72%

Live - 5344 symbols - heartbeat 94s ago · 2026-10-08 07:58

Pre-market 61.32 0.00%

After-hours 61.32 0.00%

Market cap: 1.39B
P/E (TTM): -511.00
P/B: 1.15
EPS: 2.05
Div yield: 2.56%
52W pos: 80%

Reader sentiment Are you bullish or bearish on SCL?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Fair

Altman Z-Score is 2.70, in the 1.8-3.0 "grey zone".
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +6.96% YoY

Margins

Gross margin: 11.57%
Operating margin: 2.98%
Net margin: 2.01%

Key ratios & quality

Enterprise value: 1.89B
Altman Z-Score: 2.70

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	1.99B	1.86B	1.87B	2.35B	2.77B	2.33B	2.18B	2.33B
Gross profit	339.35M	339.71M	383.61M	395.81M	427.07M	277.60M	272.21M	269.89M
Selling & admin expenses	135.56M	139.53M	142.91M	152.09M	161.21M	141.57M	143.91M	139.56M
Research & development	54.26M	55.04M	57.99M	62.69M	66.63M	59.04M	55.67M	59.28M
Operating profit	151.85M	129.31M	172.37M	174.69M	208.41M	73.00M	70.83M	69.38M
Pretax profit	137.77M	125.90M	171.07M	172.54M	188.70M	48.39M	60.44M	59.90M
Tax	26.66M	22.80M	43.41M	34.64M	41.55M	8.19M	10.07M	13.01M
Net profit	111.11M	103.10M	127.66M	137.90M	147.15M	40.20M	50.37M	46.90M
Basic EPS	5	4	6	6	6	2	2	2
Diluted EPS	4.76	4.42	5.45	5.92	6.38	1.75	2.20	2.05

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Revenue	593.26M	594.69M	590.28M	553.89M	604.51M	684.11M
Gross profit	75.46M	71.89M	71.02M	51.52M	64.85M	99.98M
Selling & admin expenses	33.52M	37.46M	34.16M	34.41M	33.48M	39.07M
Research & development	14.65M	14.70M	14.23M	15.70M	14.99M	17.20M
Operating profit	28.29M	17.97M	21.79M	1.34M	15.82M	42.32M
Pretax profit	24.66M	13.79M	16.52M	4.94M	-54.49M	32.55M
Tax	4.95M	2.45M	5.68M	-65.00K	-13.08M	9.64M
Net profit	19.71M	11.34M	10.84M	5.00M	-41.41M	22.91M
Basic EPS	1	1	0	0	-2	1
Diluted EPS	0.86	0.50	0.47	0.22	-1.81	1.00

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	833.89M	818.79M	905.65M	913.37M	1.04B	851.88M	810.43M	858.96M
Cash & ST investments	300.19M	315.38M	349.94M	159.19M	173.75M	129.82M	99.67M	132.69M
Inventory	231.53M	203.65M	218.78M	305.54M	402.53M	265.56M	288.72M	298.83M
Total assets	1.51B	1.58B	1.75B	2.07B	2.43B	2.36B	2.30B	2.36B
Total current liabilities	338.58M	339.11M	416.55M	500.48M	670.65M	607.87M	669.03M	666.49M
Short-term debt	37.06M	23.57M	37.86M	40.72M	132.11M	252.90M	292.81M	285.74M
Long-term debt	239.02M	198.53M	160.81M	322.86M	455.03M	401.25M	332.63M	340.98M
Total liabilities	706,429,000.00	686,871,000.00	763,971,000.00	991,419,000.00	1,267,107,000.00	1,146,864,000.00	1,134,714,000.00	1,113,692,000.00
Total equity	808.19M	892.50M	988.37M	1.07B	1.17B	1.22B	1.17B	1.24B
Retained earnings	837.11M	922.46M	1.02B	1.13B	1.25B	1.26B	1.27B	1.29B

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Total current assets	897.16M	914.77M	929.08M	858.96M	906.24M	974.76M
Cash & ST investments	107.49M	88.90M	118.54M	132.69M	140.78M	113.71M
Inventory	309.33M	329.48M	324.27M	298.83M	289.02M	324.46M
Total assets	2.39B	2.42B	2.43B	2.36B	2.33B	2.39B
Total current liabilities	739.48M	677.83M	713.92M	666.49M	720.45M	847.00M
Short-term debt	328.48M	274.79M	298.37M	285.74M	323.31M	403.29M
Long-term debt	330.80M	383.24M	357.11M	340.98M	328.42M	244.07M
Total liabilities	1,189,145,000.00	1,174,417,000.00	1,185,512,000.00	1,113,692,000.00	1,140,313,000.00	1,180,620,000.00
Total equity	1.20B	1.24B	1.25B	1.24B	1.19B	1.21B
Retained earnings	1.28B	1.29B	1.29B	1.29B	1.24B	1.25B

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	171.13M	218.43M	235.22M	72.14M	160.76M	174.88M	162.05M	147.88M
Depreciation & amortization	81.12M	78.70M	81.86M	90.88M	94.65M	105.34M	112.20M	126.04M
Free cash flow	84.48M	112.86M	109.42M	-122.35M	-140.79M	-85.46M	39.28M	25.37M
Dividends paid	-20.86M	-23.10M	-25.41M	-28.08M	-30.57M	-32.87M	-33.95M	-35.03M
Stock buybacks / issuance	-15.50M	-13.18M	-15.25M	-16.97M	-24.95M	--	--	--
Ending cash balance	300.19M	315.38M	349.94M	159.19M	173.75M	129.82M	99.67M	132.69M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Operating cash flow	6.94M	11.19M	69.76M	59.99M	16.93M	8.36M
Depreciation & amortization	29.27M	31.29M	32.75M	32.74M	32.95M	30.92M
Free cash flow	-25.81M	-14.41M	40.21M	25.37M	-13.95M	-15.04M
Dividends paid	-8.68M	-8.70M	-8.71M	-8.93M	-8.96M	-8.98M
Stock buybacks / issuance	--	--	--	--	--	--
Ending cash balance	107.49M	88.90M	118.54M	132.69M	140.78M	113.71M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	14.80	12.31	13.50	13.37	13.14	3.37	4.22	3.89
ROA %	7.63	6.73	7.61	7.22	6.54	1.68	2.16	2.01
ROIC %	11.62	9.80	10.99	10.43	9.39	2.69	3.29	3.40
5-year avg ROE %	13.58	13.91	13.82	13.61	13.30	11.10	9.52	7.60
EBIT margin %	7.65	7.40	9.55	7.65	7.20	2.77	3.66	3.69
FCF / sales %	4.24	6.07	5.85	--	--	--	1.80	1.09
Current ratio	2.46	2.41	2.17	1.82	1.56	1.40	1.21	1.29
Quick ratio	1.71	1.75	1.56	1.16	0.91	0.91	0.73	0.78
Debt / assets	18.23	15.94	14.28	20.35	26.21	30.13	29.63	28.67
LT debt / equity	29.60	25.59	21.52	35.33	43.36	37.75	33.34	31.38
Interest coverage	12.11	11.81	23.57	25.62	18.33	4.03	4.11	3.28
Revenue CAGR (3Y) %	3.93	1.72	-0.97	5.57	14.27	7.55	-2.41	-5.61
Net income CAGR (3Y) %	13.51	6.16	7.95	7.44	12.58	-31.81	-28.50	-31.70
FCF CAGR (3Y) %	9.49	1.14	-3.10	--	--	--	--	--

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
ROE %	4.65	4.77	3.67	3.89	-1.19	-0.22
ROA %	2.36	2.43	1.87	2.01	-0.60	-0.11
ROIC %	2.93	3.01	2.31	3.40	-0.75	-0.14
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	3.96	3.86	3.70	3.69	3.14	4.03
FCF / sales %	0.09	--	1.39	1.09	1.59	1.50
Current ratio	1.21	1.35	1.30	1.29	1.26	1.15
Quick ratio	0.74	0.78	0.78	0.78	0.80	0.72
Debt / assets	29.97	29.31	29.09	28.67	29.95	28.94
LT debt / equity	32.30	34.90	32.82	31.38	31.47	23.85
Interest coverage	--	--	--	3.28	--	--
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Single-engine

Surfactants is the largest reported line at 70.73% of revenue, across 3 reported segments.
The next-largest line, Polymers, is a distant second at 26.02% - a sharp slowdown here would have little to offset it.

Revenue breakdown most recent period

Business

Surfactants70.73%

Polymers26.02%

Specialty products3.25%

Quote time 2026-10-08 07:58:30 · For reference only, not investment advice and not tailored to your situation.